Maiwald Magazine

Press Coverage

13 Jul 2022 - Press Coverage

Royalty Pharma agrees to acquire Royalty Interest in Trelegy Ellipta from Theravance and Innoviva for $1.31 Billion and potential Milestones of $300 Million

• Further diversifies Royalty Pharma’s portfolio with market-leading respiratory therapy• Expected to significantly add to long-term Adjusted Cash Receipts growth (non-GAAP) NEW YORK, NY,...

30 Jun 2022 - Press Coverage

Royalty Pharma acquires Royalty interest in Gavreto from Blueprint medicines for up to $340 Million

Attractive, precision oncology therapy with long patent duration added to portfolioBlueprint Medicines to receive $175 million upfront and $165 million in potential milestone payments

29 Jun 2022 - Press Coverage

Bayer withdraws second PI in Nexavar battle against generic drug manufacturers

Stada, Zentiva and four other generic drug companies can launch their generic products after Bayer withdrew its second application for a preliminary injunction to protect its cancer drug, Nexavar. But the companies could still face a costly damages claim if the court ultimat...

Maiwald in the press

Publications

19 Sep 2022 - Publication

Germany cancels agreement with Switzerland on the use of trademarks, 2022

In the September edition of Managing Intellectual Property Susanna Heurung

16 Aug 2022 - Publication

Ergänzende Schutzzertifikate – Überblick und Ausblick zur EU-Initiative, Arzneimittel & Recht, 2022

SPCs are currently based on Regulation (EC) No. 469/2009 on the supplementary protection certificate for medicinal products. Under a current EU initiative, the Commission is p...

15 Aug 2022 - Publication

Originator vs Generika – Pharmapatente im Spannungsfeld des einstweiligen Verfügungsverfahrens, PharmR Heft 6/2022, Heft 8/2022

In the issue 6/2022 of Pharma Recht, Dr Marco Stief and Dr ...

All publications

Events

Sat.

15 Oct 2022

Maiwald @ APAA 2022 in South Korea

The 73rd council meeting of the Asian Patent Attorneys Association (APAA 2022) will take place in Busan from October 15 to 18. Maiwald will be represented on site by Dr Berthold Lux, Angela Zumstein and

Wed.

14 Sep 2022 - Reports

Maiwald Hiking Day 2022

This year’s company excursion took us on a relaxed hike around Lake Tegernsee in the direction of Gut Kaltenbrunn. Regardless of whether it was a short hiking route or an extended tour, in the end we all arrived at the meeting point to enjoy the afternoon together. Due to excellent food, great music and good mood, the day was a complete success.

All events

News and Releases

Maiwald Blog

No Interruption of Forfeiture Periods in the Event of Negligent Legal Action

News from Brussels – Stricter rules on pesticides and human substances for medical treatments & therapies

Free samples of medicinal products to pharmacists – Section 7 (1) Health Services and Products Advertising Act (HWG)

Press Coverage

Royalty Pharma agrees to acquire Royalty Interest in Trelegy Ellipta from Theravance and Innoviva for $1.31 Billion and potential Milestones of $300 Million

Royalty Pharma acquires Royalty interest in Gavreto from Blueprint medicines for up to $340 Million

Bayer withdraws second PI in Nexavar battle against generic drug manufacturers

Staff News

Maiwald appoints Dr Gisela Grabow as Counsel/ Tobias Matschke becomes Principal

Maiwald Congratulates on Passing the EQE Examination

Dr Ulrike Herr takes up role as partner with Maiwald

Publications

Germany cancels agreement with Switzerland on the use of trademarks, 2022

Ergänzende Schutzzertifikate – Überblick und Ausblick zur EU-Initiative, Arzneimittel & Recht, 2022

Originator vs Generika – Pharmapatente im Spannungsfeld des einstweiligen Verfügungsverfahrens, PharmR Heft 6/2022, Heft 8/2022

Awards

FOCUS List of Top Commercial Law Firms in Germany 2022

IAM Strategy 300 2022

Who’s Who Legal 2022

Events

Maiwald @ APAA 2022 in South Korea

Maiwald Hiking Day 2022